Early Antibiotic Stopping Emerges as a Measurable Outpatient Problem in Eastern Ethiopia
Oral antibiotics only work when patients finish the prescribed course, yet real-world discontinuation remains one of the most persistent threats to effective infection control. In Harar, Eastern Ethiopia, investigators tracked short-term oral antibiotic discontinuation among outpatients at public hospitals to measure how often therapy was stopped early and which patient or treatment factors were linked to that behavior.
The study used a facility-based prospective follow-up design across all public hospitals in Harar, with recruitment drawn from Hiwot Fana Comprehensive Specialized Hospital and Jugal General Hospital between 20 January and 20 April 2024. A total of 422 patients who received short-term oral antibiotics were enrolled using systematic random sampling. Four hundred completed follow-up and entered the final analysis. The cohort was relatively young on average, with a mean age of 35.89 years, and women made up 70.0% of participants.
Early discontinuation is not a minor adherence lapse. When patients stop antibiotics before the prescribed end date, bacterial burden can persist, symptoms can recur, and the selective pressure for resistant organisms can intensify. In busy outpatient pharmacies, the full clinical story often unfolds after the prescription has already left the dispensing window, which is why prospective follow-up studies are so useful: they capture the gap between intended therapy and what patients actually do at home.
Prospective Follow-up Captured Leftover Antibiotics as the Main Outcome Signal
The primary endpoint was discontinuation of short-term oral antibiotic therapy, measured through self-reported leftover antibiotics. This is a pragmatic way to capture non-completion in routine care, especially where refill data or pill counts are unavailable. Multivariable logistic regression was used to identify factors associated with discontinuation, and adjusted odds ratios with 95% confidence intervals were planned for the final analysis.
Because the study recruited patients directly from outpatient pharmacy units, the design reflects a real-world treatment pathway rather than a tightly controlled trial environment. That matters clinically. Infections treated on an outpatient basis often depend on clear counseling, patient understanding, symptom improvement, and access to medicines over several days. Any break in that chain can turn a short course into an incomplete one, even when the initial prescription was entirely appropriate.
The article excerpt available here ends before the numerical prevalence estimate and the individual predictor estimates are presented. Even so, the clinical framing is clear: the study was built to quantify a common adherence failure and then separate simple non-completion from the factors most likely to drive it. In antibiotic stewardship, those details matter because they determine whether intervention should focus on counseling, access, adverse effects, symptom relief, or broader patient education.
Why Short Courses Are Vulnerable to Premature Discontinuation
Short-term antibiotic regimens are often prescribed for common outpatient infections, where symptoms can improve quickly and patients may assume treatment is no longer necessary. That early improvement can be misleading. Symptom relief does not always mean microbiologic cure, and patients who stop once they feel better may leave behind the organisms most capable of surviving exposure. In communities where antibiotics are widely used through outpatient pharmacy services, this pattern can quietly erode the effectiveness of first-line agents.
The prospective design in Harar is especially relevant because it examines behavior in the setting where the prescription is actually filled and used. Hospital outpatient departments are a critical point of intervention: counseling at dispensing may be the only direct interaction patients have before they decide whether to continue therapy. A study built around leftover medication links patient behavior to a concrete, observable endpoint instead of relying on recall about adherence alone.
The demographic pattern in the cohort also deserves attention. With a mean age of 35.89 years and a predominantly female sample, the data reflect a large adult outpatient population rather than a narrowly selected inpatient group. That broadens the public-health relevance of the findings, since outpatient antibiotic use is where most community-level exposure and misuse occurs.
Stewardship Depends on Knowing Who Stops Therapy Early
Infections treated with oral antibiotics are only as well controlled as the adherence behind them. If a patient stops after a few days, the prescription may still have been technically correct, but the biologic effect is truncated before eradication is complete.
The study’s value lies in its attempt to move beyond counting incomplete courses and toward identifying the predictors that could be targeted in daily practice. Once those predictors are fully reported, hospital pharmacists and outpatient clinicians could use them to focus counseling on the patients most likely to discontinue treatment early. That would be especially important in settings where staffing, follow-up systems, and access to adherence supports are limited.
This also speaks to a broader antimicrobial stewardship issue in low- and middle-income settings: incomplete courses are often invisible until they accumulate into resistance pressure across a community. A patient who stops therapy early does not merely lose personal treatment benefit; the decision may also contribute to the pool of partially treated infections circulating through the same care network.
The Missing Numerical Results Limit Interpretation of the Full Signal
The excerpt supplied from the BMJ Open article provides the study question, design, population, and analytic approach, but not the final prevalence estimate or the adjusted predictors. Without those values, the exact magnitude of discontinuation in Harar cannot be stated here, and neither can the specific drivers of early stopping.
Even so, the clinical logic behind the work is strong. A prospective outpatient study in two public hospitals can identify where antibiotic adherence breaks down in routine practice and create a foundation for targeted counseling, pharmacy-based education, and stewardship interventions. The next layer of interpretation depends on the full regression results, because the practical response will differ if discontinuation is linked mainly to symptom improvement, adverse effects, demographic factors, or treatment-related barriers.